
The COAT Trial: Evaluating Ocular Surface Health in DED
The COAT trial was a multilabel phase 4 study that evaluated the efficacy of a 0.09% cyclosporine solution administered twice daily to patients over a 28-day period. Assessments occurred at baseline and on days 7, 14, and 28, tracking various clinical …